Northlane Capital Partners, Science Care, medicine, healthcare, organ transplant, medical, private equity, merger, m&a

Northlane’s Science Care, non-transplant human tissue bank, seeks buyer

Northlane Capital Partners is evaluating the sale of Science Care, a company that collects and distributes non-transplant body parts for medical research and surgeon training, according to four sources. Piper Jaffray has been engaged to offer sell-side financial advice on the sales process, the sources said. Phoenix, Arizona-based Science Care posted $20 million of adjusted […]

Altor Equity, Orchid Orthopedics, private equity, healthcare, orthopedics

Altor Equity’s Orchid Orthopedics approaches sale

Swedish PE firm Altor Equity Partners is nearing the sale of Orchid Orthopedic Solutions, according to three sources. Nordic Capital has emerged as the frontrunner to win the process for the Holt, Michigan, provider of outsourcing services in the orthopedic implants industry, one of the sources said. The anticipated transaction would conclude a Piper Jaffray-conducted […]

Revelstoke Capital Partners, Crossroads Treatment Centers, private equity, merger, M&A, healthcare, behavioral health

Crossroads, Revelstoke-backed opioid-treatment provider, heads to auction block

About four years into its investment, Revelstoke Capital Partners is bringing Crossroads Treatment Centers back to market, according to two people familiar with the matter. Harris Williams has been enlisted to run a sales process for the Greenville, South Carolina, network of opioid-treatment clinics, the people said. The process is expected to formally kick off in […]

CORE, Frazier Healthcare Partners, orthodpedics, senior citizen, private equity, merger, M&A

CORE, Frazier Healthcare-backed orthopedic group, readies for sale

CORE Institute, one of the first orthopedic care groups to attract private equity investment, is gearing up for a sales process, according to people familiar with the matter. Houlihan Lokey has been engaged to provide financial advice to the Phoenix company, people said. A formal process is expected to launch around the end of January […]

Webster Capital, Bristol Hospice, healthcare, private equity, merger, M&A

PE-backed Hospice Compassus taps adviser for upcoming sales process

Private equity-backed Hospice Compassus, one of the nation’s largest providers of hospice-care services, is prepping for a sales process, according to three people familiar with the matter. Jefferies has been engaged to provide financial advice to the Bay City, Michigan, company, which is jointly owned by Formation Capital and Audax Private Equity, two of the […]

Bain Capital, Double Impact Fund, healthcare, HealthDrive, senior citizens, merger, M&A

Bain Double Impact Fund doubles down on healthcare, adding HealthDrive

Echoing major themes supported by its large-cap fund, Bain Capital Double Impact is proving a devoted investor in healthcare providers serving some of the nation’s most vulnerable populations. Bain’s impact-investing arm said Jan. 3 that it acquired specialty physician services company HealthDrive from Riverside Partners. This follows the firm’s October formation of Arosa+LivHOME, a non-medical homecare company […]

Baymark Health Services, Webster Capital, opioid treatment, addiction, healthcare, private equity, merger, M&A

BayMark, Webster-backed opioid-treatment company, preps for sales process

BayMark Health Services, the nation’s largest network of clinics treating individuals suffering from opioid addiction, is gearing up for a sales process, Buyouts has learned. Webster Capital has enlisted Goldman Sachs to advise on a process for Lewisville, Texas-based BayMark, people familiar with the matter said. A formal auction is poised to launch in the […]

KKR. TPG, Veritas Capital, private equity, healthcare, mergers, M&A

KKR and Veritas support 2018’s largest healthcare PE deals

Private equity continued to fuel billions of dollars of healthcare deal flow in 2018, with KKR, Veritas Capital and TPG behind some of the year’s most sizable trades. AthenaHealth may have dominated headlines, but the biggest check went to physician-outsourcing giant Envision. KKR, continuing on its healthcare tear, claimed control of Envision in a $9.9 billion […]


WCAS, Linden, Cressey drive healthcare fundraising momentum in 2018

Led by three buyout firms, the healthcare private equity industry is on the brink of another record year of fundraising, according to Preqin. The healthcare private equity industry holds $199 billion in assets under management, including a record $56 billion in dry powder, the data provider said in a December report. Welsh, Carson, Anderson & […]


GP confidence high moving into 2019, even as markets flail

As 2019 approaches, indications of change are emerging in pockets of the private equity industry, but underlying industry dynamics ought to fuel a steady level of sponsor-led dealmaking for the foreseeable future. “It just feels like Groundhog Day continues, meaning the story is really the same,” said John Dickie, co-head of private equity USA at […]


Dialysis company American Renal seeks buyer

Dialysis-services provider American Renal Associates is evaluating a potential sale, according to people familiar with the matter. The Beverly, Massachusetts, public company engaged Guggenheim Partners for financial advice, the people said. The process is well underway, one of the people said. The process for ARA — the fourth-largest U.S. provider of dialysis services — comes as its […]

Carlyle Group, Nautic Partners, Odyssey Behavioral, mental health, healthcare, private equity, merger, M&A

Carlyle buys Nautic’s Odyssey Behavioral in $200 mln deal

Carlyle Group acquired Odyssey Behavioral Health from Nautic Partners in a deal valued at about $200 million, according to people familiar with the matter. The deal closed in mid-November and was done through Carlyle’s U.S. middle-market buyout group, one of the people said. The transaction has not been formally announced by the parties. Nautic, Providence, Rhode […]

Healthcare, M&A, private equity, investment bank

U.S. Renal, backed by Leonard Green, Frazier Healthcare, explores sale

U.S. Renal Care, the third-largest U.S. provider of dialysis services, is evaluating a sale, according to people familiar with the matter. The company’s investor group, which includes Leonard Green & Partners, Frazier Healthcare Partners, New Enterprise Associates, Cressey & Co and SV Health Investors, has engaged Goldman Sachs for financial advice on a process, the […]